4-[O(6)-(4-BROMOTHENYL)-GUAN-9-YL]-BUTYL-BETA-D-TETRA-O-ACETYL-GLUCOPYRANOSIDE
Compound with spectra: 1 NMR
![4-[O(6)-(4-BROMOTHENYL)-GUAN-9-YL]-BUTYL-BETA-D-TETRA-O-ACETYL-GLUCOPYRANOSIDE](/api/compound/52HcU1v8Avn.png?ph=true&h=300&w=458 "4-[O(6)-(4-BROMOTHENYL)-GUAN-9-YL]-BUTYL-BETA-D-TETRA-O-ACETYL-GLUCOPYRANOSIDE")
| SpectraBase Compound ID | 52HcU1v8Avn |
|---|---|
| InChI | InChI=1S/C28H34BrN5O11S/c1-14(35)40-11-20-22(42-15(2)36)23(43-16(3)37)24(44-17(4)38)27(45-20)39-8-6-5-7-34-13-31-21-25(34)32-28(30)33-26(21)41-10-19-9-18(29)12-46-19/h9,12-13,20,22-24,27H,5-8,10-11H2,1-4H3,(H2,30,32,33)/t20-,22-,23+,24-,27-/m1/s1 |
| InChIKey | KZJVBIUMBBLBIQ-UFOFBUIZSA-N |
| Mol Weight | 728.6 g/mol |
| Molecular Formula | C28H34BrN5O11S |
| Exact Mass | 727.115891 g/mol |
| Enantiomer InChIKey | KZJVBIUMBBLBIQ-HTYBUZFNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(O(6)-BENZYLGUAN-9-YL)-ETHYL-BETA-D-TETRA-O-ACETYL-GLUCOPYRANOSIDE
2-(8-AZA-O(6)-BENZYL-GUAN-9-YL)-ETHYL-BETA-D-TETRA-O-ACETYL-GLUCOPYRANOSIDE
5-[2-[3-(2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOSYLOXY)-PROPYLOXY]-PHENYL]-10,15,20-TRITOLYLPORPHYRINE
#11;(4-O-ACETOXYMETHYL)-BENZYL-O-(2,3,4,6-TETRA-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-(1->4)-O-(2,3,6-TRI-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-(1->4)-O-2,3,6-TRI-O-A
5-[4-[3-(2,3,6,2,3,4,6-HEPTA-O-ACETYL-BETA-D-LACTOSYLOXY)-PROPYLOXY]-PHENYL]-10,15,20-TRITOLYLPORPHYRINE
.beta.-D-Glucopyranosylamine, O-2,3,4,6-tetra-O-acetyl-.beta.-D-glucopyranosyl-(1.fwdarw.4)-O-2,3,6-tri-O-acetyl-.beta.-D-glucopyranosyl-(1.fwdarw.4)-O-2,3,6-tri-O-acetyl-.beta.-D-glucopyranosyl-(1.fwdarw.4)-N-(4-methylphenyl)-, 2,3,6-triacetate
QBYSIGIETDDJLS-KHXZBAPISA-N
PASSITRIFASCIATIN-HEPTAACETATE
ALANGIONOSIDE-E-PENTAACETATE
[3-Hydroxy-2-methyl-2-(6-phthalimidohexyloxymethyl)-propyl]-hepta-O-acetyl-b-lactoside
| Title | Journal or Book | Year |
|---|---|---|
| Monosaccharide-Linked Inhibitors of O6-Methylguanine-DNA Methyltransferase (MGMT): Synthesis, Molecular Modeling, and Structure−Activity Relationships | Journal of Medicinal Chemistry | 2001 |